Sanofi pays $125 million for Denali’s RIPK1 programs
Thursday, November 1, 2018 - 18:50
in Mathematics & Economics
The deal will expand the therapeutic scope of the neurodegenerative compounds
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via